Pharma
SPT Labtech and Semarion collaborate to advance automated cell-based assay workflows
SPT Labtech, a global leader in innovative laboratory automation, today announced a strategic collaboration with Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs. The ...
Dr Jordan Lane, CSO of Ignota Labs, appointed Industry and Enterprise Fellow of Clare Hall Cambridge
Dr Jordan Lane, Chief Scientific Officer at Ignota Labs, has been appointed Industry and Enterprise Fellow of Clare Hall, Cambridge, for his extensive experience in the AI drug discovery space. ...
Cognidox launches integrated Learning Management System to strengthen compliance and training for medical device and life science companies
Cognidox announced the launch of its new Learning Management System (LMS) — a powerful tool designed to help startups and scaling organisations meet training compliance requirements with greater efficiency, transparency, and control. ...
STEM webcast series with Kari Bryon
In an exciting collaboration, UK-based webcast production company WaveFX is working with EXPLR to create an inspiring STEM webcast series aimed at equipping young people with the tools, mentorship, and real-world skills needed to thrive in today’s high-demand careers. ...
A £14.5 Billion Opening: How UK life sciences firms can lead China’s healthcare transformation
On 2 July 2025, China’s Ministry of Finance, National Health Commission, and National Disease Control Administration jointly announced a RMB 20.92 billion (£14.5 billion) Major Public Health Service Subsidy Fund for 2025. This signals a bold continuation of healthcare system modernisati...
Milner Therapeutics Symposium showcases innovation in translational science
Hosted at West Road Concert Hall in Cambridge, the Symposium brings together leading minds from academia and industry to showcase cutting-edge research and its translation into novel therapeutics. ...
Healx and SCI Ventures join forces to uncover cures for paralysis with AI-driven drug discovery
Healx, a pioneer in AI-powered drug discovery for rare and neglected conditions, has partnered with SCI Ventures - the world’s first specialist venture fund focused on curing paralysis- to accelerate the discovery and development of therapies for spinal cord injury (SCI) using artifici...
New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects
For the first time, scientists have systematically studied the genetic effects of chemotherapy on healthy tissues. Researchers from the Wellcome Sanger Institute, the University of Cambridge, Cambridge University Hospitals NHS Foundation Trust (CUH) and their collaborators analysed bloo...
4basebio introduces new branding to reflect next phase of growth enabling development of advanced genetic therapies
4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, today (01 July 2025) announced refreshed branding and the launch of its new website, reflecting the company’s continued growth and success in this rapidly advancing field. ...
Guardtech Group set for Suffolk Business Awards showcase to kick off trio of events
The Haverhill-based contamination control specialists are up for the Large Business of the Year prize next month before setting their sights on two more awards later in the year. ...